Steffen Helmling
Corporate Officer/Principal at eTheRNA immunotherapies NV
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Marijn Dekkers | M | 65 |
Novalis Lifesciences LLC
 Novalis Lifesciences LLC Investment ManagersFinance Novalis Lifesciences LLC (Novalis Lifesciences ) is a venture capital firm founded in 2013 by Marijn E. Dekkers. The firm is headquartered in Hampton, New Hampshire.
eTheRNA immunotherapies NV
 eTheRNA immunotherapies NV BiotechnologyHealth Technology eTheRNA immunotherapies NV develops novel immunotherapies to overcome cancers and infectious diseases. The company was founded by Carlo Heirman, Kris Thielemans and Sonja van Meirvenne in January 21, 2013 and is headquartered in Niel, Belgium. | 7 years |
| Kris Thielemans | M | - |
eTheRNA immunotherapies NV
eTheRNA immunotherapies NV BiotechnologyHealth Technology eTheRNA immunotherapies NV develops novel immunotherapies to overcome cancers and infectious diseases. The company was founded by Carlo Heirman, Kris Thielemans and Sonja van Meirvenne in January 21, 2013 and is headquartered in Niel, Belgium. | 11 years |
| Antonin Rollet de Fougerolles | M | 59 |
eTheRNA immunotherapies NV
eTheRNA immunotherapies NV BiotechnologyHealth Technology eTheRNA immunotherapies NV develops novel immunotherapies to overcome cancers and infectious diseases. The company was founded by Carlo Heirman, Kris Thielemans and Sonja van Meirvenne in January 21, 2013 and is headquartered in Niel, Belgium. | 1 years |
| Bernard Sagaert | M | - |
eTheRNA immunotherapies NV
eTheRNA immunotherapies NV BiotechnologyHealth Technology eTheRNA immunotherapies NV develops novel immunotherapies to overcome cancers and infectious diseases. The company was founded by Carlo Heirman, Kris Thielemans and Sonja van Meirvenne in January 21, 2013 and is headquartered in Niel, Belgium. | - |
| Sonja van Meirvenne | F | - |
eTheRNA immunotherapies NV
eTheRNA immunotherapies NV BiotechnologyHealth Technology eTheRNA immunotherapies NV develops novel immunotherapies to overcome cancers and infectious diseases. The company was founded by Carlo Heirman, Kris Thielemans and Sonja van Meirvenne in January 21, 2013 and is headquartered in Niel, Belgium. | 11 years |
| Gregory Herrema | M | 58 |
Novalis Lifesciences LLC
Novalis Lifesciences LLC Investment ManagersFinance Novalis Lifesciences LLC (Novalis Lifesciences ) is a venture capital firm founded in 2013 by Marijn E. Dekkers. The firm is headquartered in Hampton, New Hampshire. | 2 years |
| Jeannine Caruso | F | - |
Novalis Lifesciences LLC
Novalis Lifesciences LLC Investment ManagersFinance Novalis Lifesciences LLC (Novalis Lifesciences ) is a venture capital firm founded in 2013 by Marijn E. Dekkers. The firm is headquartered in Hampton, New Hampshire. | 2 years |
| Constantine Pantelis | M | - |
Novalis Lifesciences LLC
Novalis Lifesciences LLC Investment ManagersFinance Novalis Lifesciences LLC (Novalis Lifesciences ) is a venture capital firm founded in 2013 by Marijn E. Dekkers. The firm is headquartered in Hampton, New Hampshire. | 3 years |
| Chen Yijun | M | - |
eTheRNA immunotherapies NV
eTheRNA immunotherapies NV BiotechnologyHealth Technology eTheRNA immunotherapies NV develops novel immunotherapies to overcome cancers and infectious diseases. The company was founded by Carlo Heirman, Kris Thielemans and Sonja van Meirvenne in January 21, 2013 and is headquartered in Niel, Belgium. | - |
| Anne Xie | F | - |
eTheRNA immunotherapies NV
eTheRNA immunotherapies NV BiotechnologyHealth Technology eTheRNA immunotherapies NV develops novel immunotherapies to overcome cancers and infectious diseases. The company was founded by Carlo Heirman, Kris Thielemans and Sonja van Meirvenne in January 21, 2013 and is headquartered in Niel, Belgium. | - |
| Carlo Heirman | M | - |
eTheRNA immunotherapies NV
eTheRNA immunotherapies NV BiotechnologyHealth Technology eTheRNA immunotherapies NV develops novel immunotherapies to overcome cancers and infectious diseases. The company was founded by Carlo Heirman, Kris Thielemans and Sonja van Meirvenne in January 21, 2013 and is headquartered in Niel, Belgium. | 11 years |
| Devin Leake | M | - |
Novalis Lifesciences LLC
Novalis Lifesciences LLC Investment ManagersFinance Novalis Lifesciences LLC (Novalis Lifesciences ) is a venture capital firm founded in 2013 by Marijn E. Dekkers. The firm is headquartered in Hampton, New Hampshire. | 3 years |
| Vincent Brichard | M | - |
eTheRNA immunotherapies NV
eTheRNA immunotherapies NV BiotechnologyHealth Technology eTheRNA immunotherapies NV develops novel immunotherapies to overcome cancers and infectious diseases. The company was founded by Carlo Heirman, Kris Thielemans and Sonja van Meirvenne in January 21, 2013 and is headquartered in Niel, Belgium. | - |
| Paul Meister | M | 71 |
Novalis Lifesciences LLC
Novalis Lifesciences LLC Investment ManagersFinance Novalis Lifesciences LLC (Novalis Lifesciences ) is a venture capital firm founded in 2013 by Marijn E. Dekkers. The firm is headquartered in Hampton, New Hampshire. | - |
| Alexandra Tolia | M | - |
eTheRNA immunotherapies NV
eTheRNA immunotherapies NV BiotechnologyHealth Technology eTheRNA immunotherapies NV develops novel immunotherapies to overcome cancers and infectious diseases. The company was founded by Carlo Heirman, Kris Thielemans and Sonja van Meirvenne in January 21, 2013 and is headquartered in Niel, Belgium. | - |
| Frank Kalkbrenner | M | - |
eTheRNA immunotherapies NV
eTheRNA immunotherapies NV BiotechnologyHealth Technology eTheRNA immunotherapies NV develops novel immunotherapies to overcome cancers and infectious diseases. The company was founded by Carlo Heirman, Kris Thielemans and Sonja van Meirvenne in January 21, 2013 and is headquartered in Niel, Belgium. | - |
| Kenneth Wils | M | - |
eTheRNA immunotherapies NV
eTheRNA immunotherapies NV BiotechnologyHealth Technology eTheRNA immunotherapies NV develops novel immunotherapies to overcome cancers and infectious diseases. The company was founded by Carlo Heirman, Kris Thielemans and Sonja van Meirvenne in January 21, 2013 and is headquartered in Niel, Belgium. | - |
| John Paul de Koning | M | 55 |
eTheRNA immunotherapies NV
eTheRNA immunotherapies NV BiotechnologyHealth Technology eTheRNA immunotherapies NV develops novel immunotherapies to overcome cancers and infectious diseases. The company was founded by Carlo Heirman, Kris Thielemans and Sonja van Meirvenne in January 21, 2013 and is headquartered in Niel, Belgium. | 8 years |
| Kenneth R. Chien | M | - |
eTheRNA immunotherapies NV
eTheRNA immunotherapies NV BiotechnologyHealth Technology eTheRNA immunotherapies NV develops novel immunotherapies to overcome cancers and infectious diseases. The company was founded by Carlo Heirman, Kris Thielemans and Sonja van Meirvenne in January 21, 2013 and is headquartered in Niel, Belgium. | 2 years |
| Vincent Ossipow | M | 55 |
eTheRNA immunotherapies NV
eTheRNA immunotherapies NV BiotechnologyHealth Technology eTheRNA immunotherapies NV develops novel immunotherapies to overcome cancers and infectious diseases. The company was founded by Carlo Heirman, Kris Thielemans and Sonja van Meirvenne in January 21, 2013 and is headquartered in Niel, Belgium. | 8 years |
| Kieran Murphy | M | - |
Novalis Lifesciences LLC
Novalis Lifesciences LLC Investment ManagersFinance Novalis Lifesciences LLC (Novalis Lifesciences ) is a venture capital firm founded in 2013 by Marijn E. Dekkers. The firm is headquartered in Hampton, New Hampshire. | 1 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Jon Lieber | M | - |
Tufts University
| 5 years |
| Guy Friedman | M | - |
Tufts University
| 4 years |
| Mona Vernon | F | - |
Tufts University
| 6 years |
| Justin Desrosiers | M | - |
Tufts University
| 4 years |
| Michael Stephen Tung | M | - |
Tufts University
| 4 years |
| Matthew Ondrejko | M | - |
Bowling Green State University
| 5 years |
| Adam T. Smith | M | 52 |
Tufts University
| 4 years |
| Daniel Ades | M | - |
Tufts University
| 4 years |
| Mitchell Yoel | M | - |
Tufts University
| 4 years |
| Josh Goldberg | M | - |
Tufts University
| 4 years |
| Justin Reid | M | - |
Tufts University
| 4 years |
| Patrick R. Kay | M | - |
Tufts University
| 4 years |
| Warren Choo | M | 45 |
Tufts University
| - |
| Justin Belmont | M | - |
Tufts University
| 4 years |
| Charles Carmel | M | - |
Tufts University
| 4 years |
| Will Brennecke | M | - |
Tufts University
| 4 years |
| Alexander Busse | M | - |
Tufts University
| 4 years |
| Andrew W. Valen | M | - |
Tufts University
| 4 years |
| Jonathan Neil Parker | M | - |
Tufts University
| 4 years |
| Jonathan Lee | M | - |
Tufts University
| 4 years |
| John Alexander Garofalo | M | - |
Tufts University
| 4 years |
| Matthew R. Potts | M | - |
Tufts University
| 4 years |
| Eric Stewart | M | - |
Tufts University
| 4 years |
| Ted Eagan | M | - |
Tufts University
| 4 years |
| Patricia Sosrodjojo | F | - |
Tufts University
| 4 years |
| Adam Winnick | M | - |
Tufts University
| 4 years |
| Ryan D. Teksten | M | - |
Tufts University
| 2 years |
| Yousef Ali Yousef Ensour | M | 54 |
Bowling Green State University
| 2 years |
| Jason Bush | M | - |
Tufts University
| 2 years |
| Hala Zeibak | F | 42 |
Tufts University
| 4 years |
| Erwin Thompson | M | - |
Tufts University
| 4 years |
| Susannah Rankin | M | - |
Tufts University
| 3 years |
| Joy Yee Joyce | F | 43 |
Tufts University
| 4 years |
| Kate Elizabeth Ryan | F | - |
Tufts University
| 2 years |
| Robin John | M | - |
Tufts University
| 4 years |
| Geoffrey Morris Chalmers | M | - |
Tufts University
| 4 years |
| David Alexandre Chang | M | - |
Tufts University
| 4 years |
| Fahad Khaled Al-Mukhaizeem | M | - |
Tufts University
| 4 years |
| Christian Chance Bauman | M | 52 |
Tufts University
| 4 years |
| Eamon Aghdasi | M | - |
Tufts University
| 4 years |
| Garrett T. Hall | M | - |
Tufts University
| 4 years |
| Maja Janko | F | - |
Tufts University
| 4 years |
| Rob Samuels | M | - |
Tufts University
| 4 years |
| Sam Warren | M | - |
Tufts University
| 5 years |
| Baris Brett | M | 49 |
Tufts University
| 4 years |
| Dave Bragg | M | - |
Tufts University
| 4 years |
| Jeff L. Andrews | M | - |
Tufts University
| 4 years |
| Anne O'Loughlin | F | - |
Tufts University
| 4 years |
| Rob J. Dezego | M | - |
Tufts University
| 4 years |
| Jonathan Siegel | M | 50 |
Tufts University
| 4 years |
| Samer Ezzeddine | M | - |
Tufts University
| 4 years |
| Matt Perry | M | - |
Tufts University
| 4 years |
| Monte R. Haymon | M | 86 |
Tufts University
| 10 years |
| Sean Greely | M | - |
Tufts University
| 4 years |
| Jonathan Sage | M | - |
Tufts University
| 4 years |
| Jonathan Ian Bloomberg | M | - |
Tufts University
| 4 years |
| Steven Epstein | M | 81 |
Tufts University
| 10 years |
| Daniel Mahoney | M | 44 |
Tufts University
| 4 years |
| Nick Ghoussaini | M | - |
Tufts University
| 4 years |
| Sam H. Pyne | M | - |
Tufts University
| 4 years |
| David O'Reilly | M | 49 |
Tufts University
| 4 years |
| Andrew Singer | M | - |
Tufts University
| 4 years |
| Robert N. Pattison | M | - |
Tufts University
| 2 years |
| Christopher Perry Conkling | M | 57 |
Tufts University
| 24 years |
| Vince Tran | M | - |
Tufts University
| 4 years |
| Rob Menn | M | - |
Tufts University
| 4 years |
| John Birkett | M | - |
Tufts University
| 4 years |
| William J. Eagan | M | - |
Tufts University
| 4 years |
| Sean Wright | M | - |
Tufts University
| 4 years |
| Joshua Alpert | M | - |
Tufts University
| 4 years |
| Spencer Jay Hempleman | M | - |
Tufts University
| 4 years |
| Mirette Kouchouk | F | - |
Tufts University
| 4 years |
| Daniel Lipton | M | - |
Tufts University
| 4 years |
| Arthur McGivern | M | - |
Tufts University
| 4 years |
| Alina Cellura | F | - |
Tufts University
| 4 years |
| Robert LaQuaglia | M | - |
Tufts University
| 5 years |
| Anish C. Patel | M | - |
Tufts University
| 4 years |
| Daniel P. Adams | M | - |
Tufts University
| 4 years |
| Papantoniou Antonios | M | - |
Tufts University
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 86 | 86.00% |
| Belgium | 15 | 15.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Steffen Helmling
- Personal Network
